Friday 14 July 2017

Research Insights on US Procedure Numbers for Orthopedic Soft Tissue Repair 2017

US Procedure Numbers for Orthopedic Soft Tissue Repair 2017 - MedPro is a new market research publication announced by Reportstack. 
General Report Contents• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The overall U.S. orthopedic soft tissue repair market is projected to experience modest growth over the forecast period, largely limited by the longer durations of some of the procedures. Although arthroscopy offers many benefits when compared to open or mini-open surgeries, the operating time for arthroscopy is much longer. This limiting factor can be solved by innovations in products, such as knotless suture anchors.
Changing American population demographics is the main driver of growth in the orthopedic soft tissue market. As the baby boomer generations reaches retirement, their need for soft tissue arthroscopic surgery increases. Soft tissue repair is required for wear and tear of tendons, ligaments and cartilage. This combined with the popularization of active lifestyles has made the need for orthopedic soft tissue repair increase. Arthroscopic surgery is becoming the preferable procedure as it is less invasive and reduces recovery time.
One major trend within the orthopedic soft tissue repair market is the shift towards all-suture anchors, also known as soft anchors. Suture anchors are used in many segments in the market and the emergence of this new segment has shifted the dynamic of some the segments. All-suture anchors are smaller than the conventional suture anchors, being 1.8 mm in diameter as opposed to 3.0 mm in diameter. Requiring a smaller drill-hole allows for difficult procedures to be performed with less damage to the bone during drilling. All-sutures have been gaining market shares and many competitors have noticed and started to enter that market.
Scope
2013-2023
Companies Mentioned
Arthrex Smith & Nephew DePuy Mitek Zimmer Biomet Conmed Linvatec MTF RTI Biologics Stryker LifeNet Health JRF Verocel Wright Medical Parcus Medical Medtronic Allosource Tissue Regenix Synthasome Artelon Integra LifeSciences Others include: Tissue banks, Ceterix, LifeLink, MedShape, Osiris Therapeutics, Rotation Medical, Vivex, etc.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
ReportstackMarket Research
###

No comments:

Post a Comment